Guardant Corp - Rega Nyata Tumbas Perusahaan Kanthi Wutuh GH

The market price of Guardant Health, Inc. (GH), currently 24538.51 as confirmed by this chart, illustrates the operations of a leader in oncology biomarker detection. Guardant Health, Inc. (GH) is implementing AI-driven DNA analysis for rapid diagnostics, investing heavily in scientific research. Management is aggressively expanding its clinical base in a drive toward profitability. FDA patents and the integration of tests into government medical protocols ensure a high barrier to entry.

Enterprise Value (EV) combines market capitalization and net debt, determining the actual cost of a full business buyout while accounting for all liabilities and liquid assets. By analyzing the company's market price inclusive of debt, an investor can see how the aggressive investments by Guardant Health (GH) into scientific research and liquid biopsy clinical trials impact the issuer's overall financial burden.